Growing Prevalence Of Target Diseases is added fuel in growth of the Proteomics Market Till 2024 by Dhanashree

Growing Prevalence Of Target Diseases is added fuel in growth of the Proteomics Market Till 2024

“Proteomics has become a powerful tool for treating various diseases such as diabetes, fatty liver, obesity, and deadly cancers. It is difficult to cure these diseases as body responses vary from person to person; to overcome this problem”

The global proteomics market is expected to reach over USD 24.8 billion by 2024 according to a new report by Grand View Research, Inc. The introduction of technologyenabled proteomics products is one of the high-impact rendering drivers for the proteomics market growth. These products find extensive applications in drug discovery, diagnostic services, and many other research areas. The increasing market penetration of these technologies, such as ESI-LC-MS (electrospray ionization liquid chromatography mass spectrometry), is expected to serve as a driver of this market. Access Full Research Report on Global Proteomics Market : http://www.grandviewresearch.com/industry-analysis/proteomics-market Proteomics has become a powerful tool for treating various diseases such as diabetes, fatty liver, obesity, and deadly cancers. It is difficult to cure these diseases as body responses vary from person to person; to overcome this problem, researcher from Ecole Polytechnique Fédérale de Lausanne and ETH Zurich in Switzerland developed method

to define metabolic differences between individuals. This is expected to drive the demand for proteomics over the forecast period. The presence of organizations such as the Human Proteome Organization promotes the development of new techniques, technologies, and training pertaining to the field of proteomics. This is expected to propel the market growth over the forecast period. Further key findings from the study suggest: 

The reagents segment dominated the product segment in 2015 and is expected to witness a lucrative growth with a CAGR of over 8.5%. Extensive usage of reagents for R&D activities and the introduction of novel biomarker-specific kits, such as Pro2PSA biomarker for prostate cancer and CA27.29biomarkers for breast cancer, are the factors responsible for its large market share.



The instruments segment is anticipated to show a significant growth over the forecast period. The major factor responsible for the growth is the rising demand for user-friendly, cost-effective, rapid, and accurate devices



In 2014, the protein microarray segment occupied over45% of the market share of the proteomics market, owing to the high usage rates of this technology. Microarray technology has the ability to track the protein interactions and performs chromatography and 2-Delectrophoresis in a comparatively lesser time.



The spectroscopy segment is one of the fastest growing segments of proteomics market. The introduction of novel technologies such as Orbitrap Mass spectroscopy and the increasing demand for rapid and accurate devices for complete analysis of proteins are the factors responsible for its fastest growth.



North America held the largest share of over 40% in 2015. The presence of favorable government initiatives and the growing adoption of personalized medicines are the key factors that can be attributed to the major revenue share in the market.



Asia Pacific is expected to be the fastest growing with a share of over 12% in 2015.The growing prevalence of chronic diseases in the developing countries is a key factor responsible for the fastest growth in Asia Pacific.

Grand View Research has segmented the proteomics market on the basis of product, technology, application, and region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare Table of Content of Global Proteomics Market Research Report: Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary 2.1. Proteomics Market - Industry Snapshot and Key Buying Criteria, 2015 Chapter 3. Proteomics Industry Outlook 3.1. Proteomics Market Segmentation 3.2. Proteomics Market Size and Growth Prospects 3.3. Proteomics Market Dynamics 3.3.1. Market driver analysis 3.3.1.1. Rise in geriatric population demanding personalized medicines 3.3.1.2. Growing demand for advanced diagnostics in targeted disease treatment 3.3.1.3. Growing prevalence of target diseases 3.3.1.4. Other drivers 3.3.2. Market restraint analysis 3.3.2.1. Presence of ambiguous regulatory framework 3.3.2.2. High procedure costs 3.4. Key Opportunities Prioritized 3.5. Industry Analysis - Porter's

3.6. Proteomic Market PESTEL Analysis, 2015 3.7. Proteomics company market share analysis, 2015 Chapter 4. Proteomics Product Outlook 4.1. Proteomics Market Share by Product, 2015 & 2024 4.2. Instruments 4.2.1. Instruments market estimates, 2013 - 2015 (USD Million) 4.2.2. Instruments market forecasts, 2016 - 2024 (USD Million) 4.3. Reagents 4.3.1. Reagents market estimates, 2013 - 2015 (USD Million) 4.3.2. Reagents market forecasts, 2016 - 2024 (USD Million) 4.4. Services 4.4.1. Services market estimates, 2013 - 2015 (USD Million) 4.4.2. Services market forecasts, 2016 - 2024 (USD Million) Chapter 5. Proteomics Application Outlook 5.1. Proteomics Market Share by Application, 2015 & 2024 5.2. Drug Discovery 5.2.1. Drug discovery market estimates, 2013 - 2015 (USD Million) 5.2.2. Drug discovery market forecasts, 2016 - 2024 (USD Million) 5.3. Clinical Diagnosis 5.3.1. Clinical diagnosis medicine market estimates, 2013 - 2015 (USD Million) 5.3.2. Clinical diagnosis medicine market forecasts, 2016 - 2024 (USD Million) 5.4. Others 5.4.1. Others market estimates, 2015 - 2024 (USD Million) 5.4.2. Others market forecasts, 2016 - 2024 (USD Million) Chapter 6. Proteomics Technology Outlook

6.1. Proteomics Market Share by Technology, 2015 & 2024 6.2. Microarray Instruments 6.2.1. Microarray instruments market estimates, 2013 - 2015 (USD Million) 6.2.2. Microarray instruments market forecasts, 2016 - 2024 (USD Million) 6.3. X-Ray Crystallography 6.3.1. X-Ray crystallography market estimates, 2013 - 2015 (USD Million) 6.3.2. X-Ray crystallography market forecasts, 2016 - 2024 (USD Million) 6.4. Spectroscopy 6.4.1. Spectroscopy market estimates, 2013 - 2015 (USD Million) 6.4.2. Spectroscopy market forecasts, 2016 - 2024 (USD Million) 6.5. Chromatography 6.5.1. Chromatography market estimates, 2013 - 2015 (USD Million) 6.5.2. Chromatography market forecasts, 2016 - 2024 (USD Million) 6.6. Protein Fractionation Systems 6.6.1. Protein fractionation systems market estimates, 2013 - 2015 (USD Million) 6.6.2. Protein fractionation systems market forecasts, 2016 - 2024 (USD Million) 6.7. Electrophoresis 6.7.1. Electrophoresis market estimates, 2013 - 2015 (USD Million) 6.7.2. Electrophoresis forecasts, 2016 - 2024 (USD Million) 6.8. Surface Plasma Resonance (SPR) Systems 6.8.1. SPR systems market estimates, 2013 - 2015 (USD Million)

6.8.2. SPR systems market forecasts, 2016 - 2024 (USD Million) Chapter 7. Proteomics Regional Outlook 7.1. Proteomics Market Share by Region, 2015 & 2024 7.2. North America 7.2.1. North America market estimates, by product, 2013 - 2015 (USD Million) 7.2.2. North America market forecasts, by product, 2016 - 2024 (USD Million) 7.2.2.1. U.S. 7.2.2.2. Canada 7.2.3. North America market estimates, by application, 2013 - 2015 (USD Million) 7.2.4. North America market forecasts, by application, 2016 - 2024 (USD Million) 7.2.4.1. U.S. 7.2.4.2. Canada 7.2.5. North America market estimates, by technology, 2013 - 2015 (USD Million) 7.2.6. North America market forecasts, by technology, 2016 - 2024 (USD Million) 7.2.6.1. U.S. 7.2.6.2. Canada 7.3. Europe 7.3.1. Europe market estimates, by product, 2013 - 2015 (USD Million) 7.3.2. Europe market forecasts, by product, 2016 - 2024 (USD Million) 7.3.2.1. Germany 7.3.2.2. UK

7.3.3. Europe market estimates, by application, 2013 - 2015 (USD Million) 7.3.4. Europe market forecasts, by application, 2016 - 2024 (USD Million) 7.3.4.1. Germany 7.3.4.2. UK 7.3.5. Europe market estimates, by technology, 2013 - 2015 (USD Million) 7.3.6. Europe market forecasts, by technology, 2016 - 2024 (USD Million) 7.3.6.1. Germany 7.3.6.2. UK 7.4. Asia Pacific 7.4.1. Asia Pacific market estimates, by product, 2013 - 2015 (USD Million) 7.4.2. Asia Pacific market forecasts, by product, 2016 - 2024 (USD Million) 7.4.2.1. Japan 7.4.2.2. China 7.4.3. Asia Pacific market estimates, by application, 2013 - 2015 (USD Million) 7.4.4. Asia Pacific market forecasts, by application, 2016 - 2024 (USD Million) 7.4.4.1. Japan 7.4.4.2. China 7.4.5. Asia Pacific market estimates, by technology, 2013 - 2015 (USD Million)

7.4.6. Asia Pacific market forecasts, by technology, 2016 - 2024 (USD Million) 7.4.6.1. Japan 7.4.6.2. China 7.5. Latin America 7.5.1. Latin America market estimates, by product, 2013 - 2015 (USD Million) 7.5.2. Latin America market forecasts, by product, 2016 - 2024 (USD Million) 7.5.2.1. Brazil 7.5.3. Latin America market estimates, by application, 2013 - 2015 (USD Million) 7.5.4. Latin America market forecasts, by application, 2016 - 2024 (USD Million) 7.5.4.1. Brazil 7.5.5. Latin America market estimates, by technology, 2013 - 2015 (USD Million) 7.5.6. Latin America market forecasts, by technology, 2016 - 2024 (USD Million) 7.5.6.1. Brazil 7.6. MEA 7.6.1. MEA market estimates, by product, 2013 - 2015 (USD Million) 7.6.2. MEA market forecasts, by product, 2016 - 2024 (USD Million) 7.6.2.1. South Africa 7.6.3. MEA market estimates, by application, 2013 - 2015 (USD Million) 7.6.4. MEA market forecasts, by application, 2016 - 2024 (USD Million) 7.6.4.1. South Africa

7.6.5. MEA market estimates, by technology, 2013 - 2015 (USD Million) 7.6.6. MEA market forecasts, by technology, 2016 - 2024 (USD Million) 7.6.6.1. South Africa Chapter 8. Competitive Landscape 8.1. Illumina, Inc. 8.1.1. Company Overview 8.1.2. Financial Performance 8.1.3. Product Benchmarking 8.1.4. Strategic Initiatives 8.2. Agilent Technologies, Inc. 8.2.1. Company Overview 8.2.2. Financial Performance 8.2.3. Product Benchmarking 8.2.4. Strategic Initiatives 8.3. Bio - Rad Laboratories, Inc. 8.3.1. Company Overview 8.3.2. Financial Performance 8.3.3. Product Benchmarking 8.3.4. Strategic Initiatives 8.4. GE Healthcare 8.4.1. Company Overview 8.4.2. Financial Performance 8.4.3. Product Benchmarking 8.4.4. Strategic Initiatives 8.5. Thermo Fisher Scientific, Inc. 8.5.1. Company Overview 8.5.2. Financial Performance

8.5.3. Product Benchmarking 8.5.4. Strategic Initiatives 8.6. Sigma - Aldrich 8.6.1. Company Overview 8.6.2. Financial Performance 8.6.3. Product Benchmarking 8.6.4. Strategic Initiatives 8.7. Roche Diagnostics 8.7.1. Company Overview 8.7.2. Financial Performance 8.7.3. Product Benchmarking 8.7.4. Strategic Initiative About Grand View Research, Inc.:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058

Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com